A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
Senko Tsukuda(National Institute of Infectious Diseases), Takaji Wakita(National Institute of Infectious Diseases), Hideki Aizaki(National Institute of Infectious Diseases), Masaya Sugiyama(National Center for Global Health and Medicine), Camille Sureau(Génomes, biologie cellulaire et thérapeutiques), Masashi Iwamoto(Rockefeller University), Koichi Watashi(Tokyo University of Science), Taichi Hojima(Osaka Electro-Communication University), Akiko Saito(Osaka Electro-Communication University), Masanori Isogawa(Nagoya City University), Ryosuke Suzuki(National Institute of Infectious Diseases), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Soichi Kojima(RIKEN), Katsumi Omagari(Nagoya City University), Yasuhito Tanaka(Kumamoto University)
Cited by 80
Related Papers
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
An atlas of human long non-coding RNAs with accurate 5′ ends
|Nature|2017|1.1k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k